These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 34609772

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combination Therapy with a JNK Inhibitor and Hepatocyte Growth Factor for Restoration of Erectile Function in a Rat Model of Cavernosal Nerve Injury: Comparison with a JNK Inhibitor Alone or Hepatocyte Growth Factor Alone.
    Lee J, Kim SW, Cho MC.
    Int J Mol Sci; 2021 Nov 24; 22(23):. PubMed ID: 34884500
    [Abstract] [Full Text] [Related]

  • 3. Chronic treatment with a combination of hepatocyte growth factor and JNK inhibitor ameliorates cavernosal veno-occlusive dysfunction: a rat model of cavernous nerve injury.
    Lee J, Son H, Kim SW, Cho MC.
    J Sex Med; 2023 May 26; 20(6):749-755. PubMed ID: 37037785
    [Abstract] [Full Text] [Related]

  • 4. Restoring erectile function by combined treatment with JNK inhibitor and HDAC inhibitor in a rat model of cavernous nerve injury.
    Lee J, Cho MC, Son H, Kim SW.
    Andrology; 2022 May 26; 10(4):758-766. PubMed ID: 35023296
    [Abstract] [Full Text] [Related]

  • 5. Combination of LIM-kinase 2 and Jun Amino-terminal Kinase Inhibitors Improves Erectile Function in a Rat Model of Cavernous Nerve Injury.
    Kim SW, Lee J, Park J, Chai JS, Oh S, Paick JS, Cho MC.
    Urology; 2019 Sep 26; 131():136-143. PubMed ID: 31202856
    [Abstract] [Full Text] [Related]

  • 6. The effects of single versus combined therapy using LIM-kinase 2 inhibitor and type 5 phosphodiesterase inhibitor on erectile function in a rat model of cavernous nerve injury-induced erectile dysfunction.
    Cho MC, Lee J, Park J, Oh S, Chai JS, Son H, Paick JS, Kim SW.
    Asian J Androl; 2019 Sep 26; 21(5):493-500. PubMed ID: 30829289
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of Jun N-terminal Kinase Improves Erectile Function by Alleviation of Cavernosal Apoptosis in a Rat Model of Cavernous Nerve Injury.
    Park J, Chai JS, Kim SW, Paick JS, Cho MC.
    Urology; 2018 Mar 26; 113():253.e9-253.e16. PubMed ID: 29203189
    [Abstract] [Full Text] [Related]

  • 8. Role of Jun amino-terminal kinase (JNK) in apoptosis of cavernosal tissue during acute phase after cavernosal nerve injury.
    Song WH, Son H, Kim SW, Paick JS, Cho MC.
    Asian J Androl; 2018 Mar 26; 20(1):50-55. PubMed ID: 28440265
    [Abstract] [Full Text] [Related]

  • 9. COX-2-10aa-PGIS gene therapy improves erectile function in rats after cavernous nerve injury.
    Lin H, Yuan J, Ruan KH, Yang W, Zhang J, Dai Y, Wang R.
    J Sex Med; 2013 Jun 26; 10(6):1476-87. PubMed ID: 23551902
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of Rho-kinase improves erectile function, increases nitric oxide signaling and decreases penile apoptosis in a rat model of cavernous nerve injury.
    Hannan JL, Albersen M, Kutlu O, Gratzke C, Stief CG, Burnett AL, Lysiak JJ, Hedlund P, Bivalacqua TJ.
    J Urol; 2013 Mar 26; 189(3):1155-61. PubMed ID: 23021998
    [Abstract] [Full Text] [Related]

  • 11. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate.
    Mulhall JP, Müller A, Donohue JF, Mullerad M, Kobylarz K, Paduch DA, Tal R, Li PS, Cohen-Gould L, Scardino PT.
    J Sex Med; 2008 May 26; 5(5):1126-1136. PubMed ID: 18331274
    [Abstract] [Full Text] [Related]

  • 12. Restoration of erectile function by suppression of corporal apoptosis, fibrosis and corporal veno-occlusive dysfunction with rho-kinase inhibitors in a rat model of cavernous nerve injury.
    Cho MC, Park K, Kim SW, Paick JS.
    J Urol; 2015 May 26; 193(5):1716-23. PubMed ID: 25444982
    [Abstract] [Full Text] [Related]

  • 13. Restoration of Cavernous Veno-Occlusive Function through Chronic Administration of a Jun-Amino Terminal Kinase Inhibitor and a LIM-Kinase 2 Inhibitor by Suppressing Cavernous Apoptosis and Fibrosis in a Rat Model of Cavernous Nerve Injury: A Comparison with a Phosphodiesterase Type 5 Inhibitor.
    Cho MC, Lee J, Park J, Kim SW.
    World J Mens Health; 2021 Jul 26; 39(3):541-549. PubMed ID: 32777863
    [Abstract] [Full Text] [Related]

  • 14. Restoration of erectile function with intracavernous injections of endothelial progenitor cells after bilateral cavernous nerve injury in rats.
    Liao CH, Wu YN, Lin YH, Syu Huang RF, Liu SP, Chiang HS.
    Andrology; 2015 Sep 26; 3(5):924-32. PubMed ID: 26311341
    [Abstract] [Full Text] [Related]

  • 15. Rectification of cavernosal fibrosis and veno-occlusive dysfunction by administration of suberoylanilide hydroxamic acid in a rat model of cavernosal nerve injury: Comparison with a PDE5 inhibitor.
    Cho MC, Lee J, Son H, Kim SW.
    Andrology; 2021 Mar 26; 9(2):720-727. PubMed ID: 33064925
    [Abstract] [Full Text] [Related]

  • 16. Administration of H2S improves erectile dysfunction by inhibiting phenotypic modulation of corpus cavernosum smooth muscle in bilateral cavernous nerve injury rats.
    Qinyu-Zeng, Shuhua-He, Fengzhi-Chen, Li-Wang, Liren-Zhong, Jialiang-Hui, Wei-Ding, Junhong-Fan, Haibo-Zhang, Anyang-Wei.
    Nitric Oxide; 2021 Feb 01; 107():1-10. PubMed ID: 33246103
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dual Strategy with Adipose-Derived Stem Cells and l-arginine Recovered Cavernosal Functions in a Rat Model of Radical Prostatectomy.
    Yilmaz-Oral D, Sezen SF, Turkcan D, Asker H, Kaya-Sezginer E, Kirlangic OF, Kopru CZ, Elci MP, Ozen FZ, Korkusuz P, Oren S, Oztekin CV, Ates I, Gur S.
    Stem Cells Dev; 2024 Jan 01; 33(1-2):43-53. PubMed ID: 37847152
    [Abstract] [Full Text] [Related]

  • 19. Chronic administration of udenafil, a selective phosphodiesterase type 5 inhibitor, promotes erectile function recovery in an animal model of bilateral cavernous nerve crush injury.
    Lee CH, Kim HS, Goo MJ, Kang KK, Ahn BO, Kim SH, Yang DY.
    J Sex Med; 2011 May 01; 8(5):1330-40. PubMed ID: 21366883
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.